Cargando…

Expression Profiles and Clinicopathologic Features in Early Resected Non-small-cell Lung Cancer()

Detalles Bibliográficos
Autor principal:	Rosell, Rafael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2014
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457345/ https://www.ncbi.nlm.nih.gov/pubmed/26137517 http://dx.doi.org/10.1016/j.ebiom.2014.10.008

Ejemplares similares

Gene Expression Signatures Predicting Survival and Chemotherapy Benefit in Patients with Resected Non-small-Cell Lung Cancer
por: Rosell, Rafael, et al.
Publicado: (2018)

Co-mutations in EGFR driven non-small cell lung cancer
por: Rosell, Rafael, et al.
Publicado: (2019)

Clinicopathological features and prognostic implications of ASCL1 expression in surgically resected small cell lung cancer
por: Wei, Jiacong, et al.
Publicado: (2020)

Deciphering Crosstalk Circuits in Non-small Cell Lung Cancers with an Increasing Interval Length of Low Dose CT Screening
por: Rosell, Rafael, et al.
Publicado: (2015)

Clinicopathological features and EGFR gene mutation status in elderly patients with resected non–small-cell lung cancer
por: Nishii, Teppei, et al.
Publicado: (2014)

PTEN and Ki67 expression is associated with clinicopathologic features of non-small cell lung cancer
por: Ji, Yong, et al.
Publicado: (2014)

Postoperative Radiotherapy in Completely Resected IIIA-N2 Non-small Cell Lung Cancer: Quit or Not?
por: Chen, Yu, et al.
Publicado: (2023)

Association of Clinicopathologic and Molecular Tumor Features With Recurrence in Resected Early-Stage Epidermal Growth Factor Receptor–Positive Non–Small Cell Lung Cancer
por: Saw, Stephanie P. L., et al.
Publicado: (2021)

Clinicopathological Factors Related to Recurrence Patterns of Resected Non-Small Cell Lung Cancer
por: Shimizu, Reiko, et al.
Publicado: (2020)

Expression of WASF3 in patients with non-small cell lung cancer: Correlation with clinicopathological features and prognosis
por: WU, JIE, et al.
Publicado: (2014)

Neoadjuvant immunotherapy with resectable non-small cell lung cancer: recent advances and future challenges
por: Ren, Sijia, et al.
Publicado: (2020)

Clinicopathological Features of Non-Small Cell Lung Carcinoma with BRAF Mutation
por: Ambrosini-Spaltro, Andrea, et al.
Publicado: (2023)

Establishment of cancer/testis antigen profiling based on clinicopathological characteristics in resected pathological stage III non-small cell lung cancer
por: Jin, Shi, et al.
Publicado: (2018)

The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer
por: Feng, Anlin, et al.
Publicado: (2016)

Impact of smoking amount on clinicopathological features and survival in non-small cell lung cancer
por: Ban, Woo Ho, et al.
Publicado: (2020)

TERT Mutations in Non–Small Cell Lung Cancer: Clinicopathologic Features and Prognostic Implications
por: Yang, Liu, et al.
Publicado: (2023)

Clinicopathologic Implication of Ezrin Expression in Non-small Cell Lung Cancer
por: Lee, Ho Won, et al.
Publicado: (2012)

Clinicopathologic features and prognostic implications of NOK/STYK1 protein expression in non-small cell lung cancer
por: Chen, Peng, et al.
Publicado: (2014)

Loss of Fhit expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological features
por: Geradts, J, et al.
Publicado: (2000)

Correlation of PD-L1 Expression with Clinicopathological and Genomic Features in Chinese Non-Small-Cell Lung Cancer
por: Li, Yue, et al.
Publicado: (2022)

Clinicopathological and computed tomography features of patients with early-stage non-small-cell lung cancer harboring ALK rearrangement
por: Hou, Xiaoming, et al.
Publicado: (2023)

Adjuvant osimertinib for resected EGFR-mutated non-small cell lung cancer: a game-changer?
por: Patel, Shruti R., et al.
Publicado: (2023)

Current and Future Perspectives of Health-Related Quality of Life in Resectable EGFR-Mutated Non-Small Cell Lung Cancer: A Podcast
por: John, Thomas, et al.
Publicado: (2022)

Targeted treatment of mutated EGFR-expressing non-small-cell lung cancer: focus on erlotinib with companion diagnostics
por: Karachaliou, Niki, et al.
Publicado: (2014)

Commentary on “Clinicopathological features of programmed cell death-ligand 1 expression in patients with oral squamous cell carcinoma”
por: Peña-Cardelles, Juan Francisco, et al.
Publicado: (2022)

Clinicopathological relevance of tumor expression of NK group 2 member D ligands in resected non-small cell lung cancer
por: Okita, Riki, et al.
Publicado: (2019)

Association between CXCL16/CXCR6 expression and the clinicopathological features of patients with non-small cell lung cancer
por: Ke, Chuangwu, et al.
Publicado: (2017)

Clinicopathological significance of oestrogen receptor expression in non-small cell lung cancer
por: Chen, Xiang-Qi, et al.
Publicado: (2016)

Chemotherapy in non-small cell lung cancer: opportunities for advancement
por: Akhtari, Mani, et al.
Publicado: (2016)

Integrated mutation, copy number and expression profiling in resectable non-small cell lung cancer
por: Newnham, Genni M, et al.
Publicado: (2011)

Adjuvant treatment with EGFR TKI in resected non-small cell lung cancer with EGFR mutation: all that glitters is not gold!
por: Fiorelli, Alfonso, et al.
Publicado: (2020)

EGFR and ERBB2 exon 20 insertion/duplication in advanced non–small cell lung cancer: genomic profiling and clinicopathologic features
por: Sompallae, Ramakrishna R., et al.
Publicado: (2023)

Pemetrexed as second-line therapy for advanced non-small-cell lung cancer (NSCLC)
por: Felip, Enriqueta, et al.
Publicado: (2008)

Keynote 407: the combination of pembrolizumab and chemotherapy cracks the shell of squamous cell lung cancer
por: Viteri, Santiago, et al.
Publicado: (2020)

Profile of alectinib for the treatment of ALK-positive non-small cell lung cancer (NSCLC): patient selection and perspectives
por: Karachaliou, Niki, et al.
Publicado: (2019)

Clinicopathologic and Imaging Features of Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations
por: Digumarthy, Subba R., et al.
Publicado: (2019)

Clinicopathological features and diagnostic methods of ALK fusion-positive non-small cell lung cancer in Korea
por: Chang, Won Chul, et al.
Publicado: (2020)

HER2-Altered Non-Small Cell Lung Cancer: Biology, Clinicopathologic Features, and Emerging Therapies
por: Yu, Xin, et al.
Publicado: (2022)

Gene Mutation and Its Association with Clinicopathological Features in Young Patients with Non-Small-Cell Lung Cancer
por: Kong, Wencui, et al.
Publicado: (2022)

Clinicopathological significance of fascin-1 expression in patients with non-small cell lung cancer
por: Ling, Xiao-Ling, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1lbvtb6ge4grv16b2nh9ig15ae